IP Library Granted Patent US 8,923,983
Granted Patent B2
US 8,923,983 · App. 12/421,547 · Granted Dec 30, 2014

Device for reducing the fault susceptibility of elongated implants

Inventors: Ingo Weiss (Berlin, DE); Stefan Knorr (Berlin, DE); Michelle Maxfield (Berlin, DE); Michael Friedrich (Kleinmachnow, DE)
Assignee: Biotronik CRM Patent AG
A61N1/056A61N1/05A61N2001/086
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,923,983
App. No.
12/421,547
Granted
Dec 30, 2014
Kind
B2
Abstract

An implantable line having an elongated line body, a function conductor extending in the longitudinal direction of the line body, acting to implement a medical function of the line, whereby in addition to the function conductor, a field decoupling conductor which extends over at least a section of the length of the line body essentially parallel to the function conductor is provided, thereby reducing the coupling of the function conductor to an external field.

Claims (21)

1. An implantable line ( 1 ) comprising:

an elongated line body;

at least one electrode comprising

a tip electrode and a ring electrode and

a first and second electrode terminal contact at opposing ends of the elongated line body;

a first and second function conductor ( 13 , 15 ) which extend in a longitudinal direction of the elongated line body that implement a medical function of the implantable line;

wherein the first and second function conductor ( 13 , 15 ) connect the tip electrode and the ring electrode to the first and second electrode terminal contact respectively;

a field decoupling conductor ( 24 ″) which extends at least between said at least one electrode to said first and second electrode terminal contact wherein said field decoupling conductor ( 24 ″) reduces coupling of the function conductor ( 13 , 15 ) to an external field wherein said field decoupling conductor is configured to terminate at a proximal end of said elongated line body within a header of an implantable medical device wherein said field decoupling conductor is a conductive liquid configured with a volume of liquid to decouple the function conductor ( 13 , 15 ) to an external field; and,

wherein said field decoupling conductor that is said conductive liquid does not electrically couple said at least one electrode comprising said tip electrode and said ring electrode to said first or said second electrode terminal contact.

2. The implantable line according to claim 1 , further comprising:

a lumen in which to insert or apply the field decoupling conductor ( 24 ″).

3. The implantable line according to claim 1 , wherein the field decoupling conductor ( 24 ″) is inside the elongated line body.

4. The implantable line according to claim 2 , further comprising:

wherein the field decoupling conductor ( 24 ″) is configured for subsequent insertion or application in a previously implanted elongated line body via injection from a tube that is inserted into said lumen with said conductive liquid and then withdrawn from said lumen without said conductive liquid, therein leaving said conductive liquid within said previously implanted elongated line body.

5. The implantable line according to claim 1 wherein said conductive liquid is an aqueous solution of salts.

6. The implantable line according to claim 1 wherein said conductive liquid comprises large ions.

7. A method of implementing the implantable line ( 1 ) comprising:

providing the implantable line of claim 2 ;

inserting a tube into the lumen with said conductive liquid;

inserting said conductive liquid into said internal lumen using said tube; and,

withdrawing said tube from said internal lumen without said conductive liquid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: BIOTRONIK CRM PATENT AG
To: BIOTRONIK SE & CO. KG
Reel/Frame 045995/0948 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2009
From: WEISS, INGO, DR.; MAXFIELD, MICHELLE; KNORR, STEFAN; FRIEDRICH, MICHAEL, DR.
To: BIOTRONIK CRM PATENT AG
Reel/Frame 022616/0517 →
Priority Claims (1)
DE 10 2008 018 990 · Apr 14, 2008 · national
Continuity (1)
Related Publication 20090259281A1 · Oct 15, 2009